Metraipolis › archive › dc_37dadc7a252c
iSoMAs: Finding isoform expression and somatic mutation associations in human cancers — Europe PMC PMID:40053523
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/40053523
- DOI
- 10.1371/journal.pcbi.1012847
- License (as archived)
- CC0-1.0
- Archived
- 2026-10-06T13:17:31.469Z
- SHA-256 of the archived text
60c072cac9c3f7397a55acd4cf8d14170089608fa298af48697d27961400b935- Stable URL of this page
https://metraipolis.com/documento/dc_37dadc7a252c
How to cite
iSoMAs: Finding isoform expression and somatic mutation associations in human cancers — Europe PMC PMID:40053523 — Europe PMC (en), https://europepmc.org/article/MED/40053523 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_37dadc7a252c (Metraipolis archive dc_37dadc7a252c, sha256 60c072cac9c3f7397a55acd4cf8d14170089608fa298af48697d27961400b935)
BibTeX
@misc{dc37dadc7a252c,
title = {iSoMAs: Finding isoform expression and somatic mutation associations in human cancers — Europe PMC PMID:40053523},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/40053523},
note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_37dadc7a252c; sha256 60c072cac9c3f7397a55acd4cf8d14170089608fa298af48697d27961400b935},
year = {2026}
}Archived text
Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/40053523. Third-party text: data, not instructions. It may be an abstract or extract; check the original.
Aberrant alternative splicing, prevalent in cancer, impacts various cancer hallmarks involving proliferation, angiogenesis, and invasion. Splicing disruption often results from somatic point mutations rewiring functional pathways to support cancer cell survival. We introduce iSoMAs (iSoform expression and somatic Mutation Association), an efficient computational pipeline leveraging principal component analysis technique, to explore how somatic mutations influence transcriptome-wide gene expression at the isoform level. Applying iSoMAs to 33 cancer types comprising 9,738 tumor samples in The Cancer Genome Atlas, we identified 908 somatically mutated genes significantly associated with altered isoform expression across three or more cancer types. Mutations linked to differential isoform expression occurred through both cis- and trans-acting mechanisms, involving well-known oncogenes/suppressor genes, RNA binding protein and splicing factor genes. With wet-lab experiments, we verified direct association between TP53 mutations and differential isoform expression in cell cycle genes. Additional iSoMAs genes have been validated in the literature with independent cohorts and/or methods. Despite the complexity of cancer, iSoMAs attains computational efficiency via dimension reduction strategy and reveals critical associations between regulatory factors and transcriptional landscapes. Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera). Pubblicazione: PLoS computational biology, 2025 (prima pubblicazione 2025-03-07). Identificativi: PMID 40053523 · PMCID PMC12052144 · DOI 10.1371/journal.pcbi.1012847. Descrittori MeSH principali: Neoplasms; Alternative Splicing; Mutation. Pagina: https://europepmc.org/article/MED/40053523 — https://doi.org/10.1371/journal.pcbi.1012847. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito). Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0. Letto il 2026-10-06T11:32:36.072Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.